Tokyo, Aug. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062725) titled 'A study investigating potassium levels in surgical patients taking Kampo medicines containing licorice' on Aug. 28.
Study Type:
Observational
Primary Sponsor:
Institute - National Hospital Organization Tokyo Medical Center
Condition:
Condition - Patients who regularly received licorice-containing Kampo medicines from the preoperative period until the day before surgery.
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study was to retrospectively evaluate perioperative changes in serum potassium levels in patients regularly taking licorice-containing Kampo medicines before surgery, to determine the incidence of hypokalemia, and to identify factors that may contribute to the risk assessment of hypokalemia.
Basic objectives2 - Safety
Eligibility:
Age-lower limit - 19
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients who regularly received licorice-containing Kampo medicines from the preoperative period until the day before surgery.
Key exclusion criteria - Patients without intraoperative serum potassium measurements, patients younger than 18 years of age, patients receiving dialysis, patients with ileus, and patients undergoing emergency surgery.
Target Size - 120
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2025 Year 09 Month 01 Day
Date of IRB - 2025 Year 09 Month 11 Day
Anticipated trial start date - 2025 Year 09 Month 11 Day
Last follow-up date - 2030 Year 08 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069592
Disclaimer: Curated by HT Syndication.
